Atypical Delayed-Onset Endophthalmitis Following Intravitreal Dexamethasone Implant Managed Without Implant Removal: A Rare Case Report and Literature Review
Romanian Journal of Ophthalmology · 2024
DOI: 10.22336/rjo.2024.64 ↗Kurz gefasst
Fallbericht in der Zeitschrift Romanian Journal of Ophthalmology, 2024. Verfasst von Amit Nandan Tripathi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Command Hospital, (Eastern Command), Kolkata, India. Hauptthemen laut MEDLINE: Dexamethasone, Endophthalmitis, Eye Infections, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To report a case of atypical delayed-onset endophthalmitis following intravitreal dexamethasone (DEX) implantation, managed successfully without implant removal. Case presentation: A 72-year-old Asian woman with recurrent macular edema due to central retinal vein occlusion (CRVO) received an intravitreal DEX implant. Two weeks post-injection, she experienced blurred vision but no pain or redness. Best-corrected visual acuity (BCVA) had dropped to hand movements near the face (HMCF). Examination revealed 3+ anterior chamber cells and a 1.5 mm hypopyon, with significant vitreous haze obscuring retinal details. A diagnosis of acute endophthalmitis was made. Initial treatment with intravitreal vancomycin and ceftazidime was followed by pars plana vitrectomy (PPV) without implant removal. Microbiological tests were negative, and vision improved significantly, with BCVA returning to 6/12 after two weeks.
Discussion
Endophthalmitis following DEX implantation is rare, and its management is not well-defined. While implant removal is often recommended, favorable outcomes can be achieved without it. The negative culture results and atypical presentation suggested a possible non-infectious etiology. Intraocular steroids may obscure typical signs of infection.
Conclusion
Atypical delayed-onset endophthalmitis following DEX implantation can be successfully treated with prompt vitrectomy and intravitreal antibiotics without implant removal, underscoring the need for individualized management in such cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Command Hospital, (Eastern Command), Kolkata, India.
- Department of Ophthalmology, Command Hospital, (Central Command), Lucknow, India.
- Department of Ophthalmology, Army Hospital, (Research & Referral), New Delhi, India.
Zitieren
APA
Tripathi, A. N., Rana, V., Bandopadhyay, S., Kaushik, J., & Kumar, P. (2024). Atypical Delayed-Onset Endophthalmitis Following Intravitreal Dexamethasone Implant Managed Without Implant Removal: A Rare Case Report and Literature Review. Romanian Journal of Ophthalmology. https://doi.org/10.22336/rjo.2024.64
Vancouver
Tripathi AN, Rana V, Bandopadhyay S, Kaushik J, Kumar P. Atypical Delayed-Onset Endophthalmitis Following Intravitreal Dexamethasone Implant Managed Without Implant Removal: A Rare Case Report and Literature Review. Romanian Journal of Ophthalmology. 2024. doi:10.22336/rjo.2024.64
BibTeX
@article{Tripathi2024,
author = {Tripathi, Amit Nandan and Rana, Vipin and Bandopadhyay, Sandepan and Kaushik, Jaya and Kumar, Pradeep},
title = {Atypical Delayed-Onset Endophthalmitis Following Intravitreal Dexamethasone Implant Managed Without Implant Removal: A Rare Case Report and Literature Review},
journal = {Romanian Journal of Ophthalmology},
year = {2024},
doi = {10.22336/rjo.2024.64}
}
EUVIMED